Compared with the control group, the tumor volume after 21 d of treatment was 88.9 ± 9.1% for DOX, 62.8 ± 5.8% for the three-agent combination, 68.9 ± 7.2% for HSA-DOX, and 49.6 ± 5.3% for the HSA–NAMI-A–Cu(BpT)Br–DOX complex (Figure 5(A)). This evidence concerns the gene ALB and neoplasm.